Magro Fernando, Sottomayor Catarina, Alves Catarina, Santiago Mafalda, Ministro Paula, Lago Paula, Correia Luís, Gonçalves Raquel, Carvalho Diana, Portela Francisco, Dias Cláudia Camila, Dignass Axel, Danese Silvio, Peyrin-Biroulet Laurent, Estevinho Maria Manuela, Leão Moreira Paula
Department of Biomedicine, Unit of Pharmacology and Therapeutics, Faculty of Medicine, University of Porto, Alameda Prof. Hernâni Monteiro, 4200-319 Porto, Portugal.
Faculty of Medicine, University of Porto, Porto, Portugal.
Therap Adv Gastroenterol. 2022 May 13;15:17562848221092754. doi: 10.1177/17562848221092754. eCollection 2022.
This systematic review and meta-analysis aims to assess composite and aggregate outcomes of observational studies in Crohn's disease and to evaluate whether the number and type of variables included affect the frequency of the outcome.
MEDLINE [via PubMed], Scopus and Web of Science were searched to identify observational studies that enrolled patients with Crohn's disease and evaluated a composite or aggregate outcome. The proportion of patients achieving the outcome was determined and a random-effects meta-analysis was performed to evaluate how the frequency of each outcome varies according to the reporting of predefined variables.
From 10,257 identified records, 46 were included in the qualitative analysis and 38 in the meta-analysis. The frequency for composite and aggregate outcomes was 0.445 [95% confidence interval (CI): 0.389-0.501] and 0.140 (95% CI: 0.000-0.211), respectively. When comparing composite outcomes by number of included variables, the frequency was 0.271 (95% CI: 0.000-0.405) and 0.698 (95% CI: 0.651-0.746), for one and six variables, respectively. The frequency of the composite outcome varied according to the identity of the variables being reported. Specific pairs of predefined variables had a significant effect in the frequency of composite outcomes.
Composite outcomes with increasing number of predefined variables show an increase in frequency. Outcomes including variables such as 'Surgery' and 'Steroids' had higher frequencies when compared with the ones that did not include these variables. These results show that the frequency of composite outcomes is dependent on the number and type of variables being reported.
本系统评价和荟萃分析旨在评估克罗恩病观察性研究的综合及总体结局,并评估纳入变量的数量和类型是否会影响结局的发生率。
检索MEDLINE[通过PubMed]、Scopus和Web of Science,以识别纳入克罗恩病患者并评估综合或总体结局的观察性研究。确定达到结局的患者比例,并进行随机效应荟萃分析,以评估每个结局的发生率如何根据预定义变量的报告情况而变化。
从10257条识别记录中,46条纳入定性分析,38条纳入荟萃分析。综合和总体结局的发生率分别为0.445[95%置信区间(CI):0.389 - 0.501]和0.140(95%CI:0.000 - 0.211)。按纳入变量数量比较综合结局时,一个变量和六个变量时的发生率分别为0.271(95%CI:0.000 - 0.405)和0.698(95%CI:0.651 - 0.746)。综合结局的发生率因所报告变量的性质而异。特定的预定义变量对综合结局的发生率有显著影响。
预定义变量数量增加的综合结局显示发生率上升。与不包括“手术”和“类固醇”等变量的结局相比,包括这些变量的结局发生率更高。这些结果表明,综合结局的发生率取决于所报告变量的数量和类型。